Comprehensive Analysis on Sleep Apnea Devices Market| Key Players: BMC Medical, Becton Dickinson, Braebon Medical Corporation, Cadwell Laboratories Inc, Compumedics Limited

The Sleep Apnea Devices Market size is set to exceed USD 9 billion by 2024; according to a new research report by Global Market Insights.

Rapid advancements in technology for sleep apnea devices coupled with growing geriatric population across the world should drive the global sleep apnea devices market growth over the forecast period. Rising prevalence of sleep apnea disorder with changing lifestyle habits such as unhealthy sleep patterns, smoking and excess alcohol consumption causes sleep related disorder and further drive industry growth.

Growing government initiatives for increasing awareness levels among people regarding sleep related diseases due to growing incidence of Obstructive Sleep Apnea (OSA) across the world. For instance, American Academy of Sleep Medicine (AASM) represents evidence-based endorsement for diagnosis and management of OSA. However, high cost associated with sleep apnea devices and lack of patient compliance should hinder industry growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/489

Rising advancement in technology for sleep apnea devices will ensure effective diagnosis and treatment which will enhance patient outcomes and upsurge demand for the product. Start-up companies are engaged in developing adjustable and automatic devices for patient comfort and also to gain revenue share.

Therapeutic devices accounted for significant revenue share in 2016. Increasing demand for highly effective therapeutic devices such as oral appliances, Adaptive Servo-Ventilation (ASV), oxygen devices and various other will drive industry growth over the forecast period.

Positive airway pressure (PAP) therapeutic device will witness robust growth over the forecast timeframe. CPAP device is cost effective and improves sleepiness, hypertension, and various cardiovascular diseases. Such factors should drive industry growth.

Respiratory polygraphs accounted for significant revenue share in 2016. Respiratory polygraphs are cost-effective, efficient, easy to use and have application in home care setting for diagnosis of sleep-related disorders. Such factors will drive segment growth over the forecast period.

U.S. sleep apnea devices market size should witness robust growth over the forecast period. Rising government initiatives, high prevalence of sleep related disorders and COPD and advanced healthcare infrastructure are the foremost factors driving sleep apnea devices market growth over the forecast timeframe.

UK should witness robust growth in sleep apnea devices market over the forecast period. Increasing funding on research activities and rising patient awareness levels regarding treatment for snoring and sleep should drive industry growth in the coming years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/489

India sleep apnea devices market should grow at significant rate over the forecast period. The growth is attributed to increasing prevalence of sleep apnea disorder and growing government initiatives to increase awareness. For instance, Indian initiative on obstructive sleep apnea guidelines (INOSA) developed under the support of Ministry of Family Welfare and Health, Department of Health Research and Government of India.

Key Players:

Some of the key players operating in sleep apnea devices includes Philips, Braebon Medical, Compumedics, ResMed, GE Healthcare, Cadwell Laboratories, Invacare, Carefusion and Fisher & Paykel Healthcare. Industry players are majorly focusing on new product launch, merger & acquisition and investment in research and development activities to gain revenue share.

Sleep Apnea Devices Market by Product

Therapeutic devices

Adaptive Servo-Ventilation Systems
Airway Clearance Systems
Oral appliances
Oxygen devices
Positive Airway Pressure (PAP) devices

Diagnostic devices

Actigraphy systems
Polysomnography (PSG) devices
Respiratory polygraphs
Single-channel screening devices (Pulse oximeters)

Chapter 3. Sleep Apnea Devices Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 – 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Presence of advanced healthcare infrastructure in North America

3.3.1.2. Growing prevalence of sleep apnea and related co-morbidities in North America

3.3.1.3. Rising demand for portable, efficient and superior sleep apnea devices

3.3.1.4. Insurance coverage for treatment of sleep apnea and other sleep disorders in U.S.

3.3.1.5. Growing awareness regarding sleep apnea and other sleep disorders

3.3.1.6. Increasing aging population putting strain on European healthcare

3.3.1.7. Product innovation strategy adopted by key industry players in Europe

3.3.2. Industry pitfalls & challenges

3.3.2.1. Clinical consequences and economic impact of sleep apnea and related sleep disorders

3.3.2.2. Lack of adherence to sleep apnea treatment

3.4. Growth potential analysis

3.4.1. By product

3.5. Regulatory landscape

3.5.1. U.S

3.5.2. Europe

3.6. Reimbursement scenario

3.7. Technology landscape

3.8. Porter’s analysis

3.9. Competitive landscape, 2016

3.9.1. Business overview

3.9.2. Revenue analysis

3.9.3. Product landscape

3.9.4. Strategy dashboard

3.10. PESTEL analysis

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.